12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersPaxMedica (NASDAQ:PXMD) stock moved upwards by 104.2% to $0.84 during Friday's pre-market session. The market value of their outstanding shares is at $6.2 million. Allarity Therapeutics (NASDAQ

BenzingaApr 12 20:09

Small-Cap Firm Century Therapeutics' Expands Into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing

Thursday, Century Therapeutics (NASDAQ:IPSC) unveiled plans to expand clinical development for its lead program, CNTY-101, a CD19-targeting iNK cell therapy, into additional autoimmune disease indicat

BenzingaApr 12 04:24

Needham: Reiterates the Nkarta (NKTX.US) rating and adjusted from buy to buy rating, target price is $15.00.

Needham: Reiterates the Nkarta (NKTX.US) rating and adjusted from buy to buy rating, target price is $15.00.

Zhitong FinanceApr 10 19:41

Needham Reiterates Buy on Nkarta, Maintains $15 Price Target

Needham analyst Gil Blum reiterates Nkarta with a Buy and maintains $15 price target.

Analyst UpgradesApr 10 19:32

Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Nkarta (NKTX)

TipRanksApr 10 19:00

Nkarta to Participate in Upcoming Investor Conferences

PDF Version SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, to

NkartaApr 3 12:00